Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
03/2007
03/08/2007US20070053835 Antibodies (monoclonal, humanized) conjugated to antigrowth/cytotoxic agents (maytansinoids, calicheamicins); host cells
03/08/2007US20070053834 Radioligands for the TRP-M8 receptor and methods therewith
03/08/2007US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders
03/08/2007US20070053832 Drug product and process for making
03/08/2007US20070053831 Methods for binding agents to b-amyloid plaques
03/08/2007US20070053830 Particulate materials and compositions for radio therapy
03/08/2007CA2619941A1 F-18 peptides for pre targeted positron emission tomography imaging
03/07/2007EP1760056A1 A convenient method for the preparation of no-carrier-added O-(2-[18F]fluoroethyl)-L-Tyrosine)
03/07/2007EP1560603B1 Method for measuring pancreatic metabolism
03/07/2007EP1257695B1 Biomolecules having multiple attachment moieties for binding to a substrate surface
03/07/2007EP1017817B1 Mutants of thyroid stimulating hormone
03/07/2007CN1925878A Contrast agents for myocardial perfusion imaging
03/07/2007CN1925876A Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
03/06/2007US7186808 Isolated monoclonal antibody encoded by clone accession number PTA-4889.
03/06/2007US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186414 Improved bioavailability; for oral and intracolonic administration
03/06/2007US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
03/06/2007US7186399 Complexing; binding epitopes to surfaces; imaging; detection thrombosis, infections, cancer; acoustic reflection
03/06/2007US7186398 Fe/Au nanoparticles and methods
03/06/2007US7186397 Cancer diagnosis; antitumor agents
03/01/2007WO2007025282A2 Use of fructose-based compounds for the diagnosis of cancer
03/01/2007WO2006064451A3 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy
03/01/2007US20070049735 Antibodies that bind both bcma and taci
03/01/2007US20070049519 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals
03/01/2007US20070048752 Mass tags for quantitative analyses
03/01/2007US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor
03/01/2007US20070048319 Antibodies that bind both bcma and taci
03/01/2007US20070048223 Cytokine receptor zcytor17 multimers
03/01/2007US20070048222 Cytokine receptor zcytor17 multimers
03/01/2007US20070048221 Antibodies that bind both bcma and taci
03/01/2007US20070048220 Antibodies that bind both bcma and taci
03/01/2007US20070048219 drug/polymer and biological conjugates/, used as angiogenesis inhibitors, for diagnosis and therapy of vision disorders
03/01/2007US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor
03/01/2007US20070048217 F-18 peptides for pre targeted positron emission tomography imaging
03/01/2007US20070048216 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/01/2007US20070048215 Chemical compound and assay
02/2007
02/28/2007EP1757695A2 Prostate-specific membrane antigen
02/28/2007EP1757694A2 Prostate-specific membrane antigen
02/28/2007EP1756318A2 Aptamer-toxin molecules and method for using same
02/28/2007EP1756166A1 Prostate cancer diagnosis and treatment
02/28/2007EP1755686A2 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
02/28/2007EP1581538B1 Tetracyclic 3-substituted indoles having serotonin receptor affinity
02/28/2007EP1381397B1 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
02/28/2007EP1275645B1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
02/28/2007EP1257575B1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
02/28/2007EP1045838B1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
02/28/2007EP0889739B1 Measurement of gastric emptying
02/28/2007CN1921893A Catalytic radiofluorination
02/28/2007CN1301750C Conjugates of macrocyclic metal complexes with biomolucules and utilization thereof for producing agents for use in NMR diagnosis and radiodiagnosis and radiotherapy
02/27/2007US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
02/27/2007US7182934 Contrast agents
02/22/2007WO2007021858A2 Methods of making radiolabeled tracers and precursors thereof
02/22/2007WO2006118916A3 Methods and compositions for polytopic vaccination
02/22/2007WO2005120582A3 Compositions and methods for inhibiting expression of hypoxia-inducible genes
02/22/2007US20070043289 Method and Apparatus Including Use of Metalloporphyrins for Subsequent Optimization of Radiosurgery and Radiotherapy
02/22/2007US20070042942 Glycopeptide carboxy-saccharide derivatives
02/22/2007US20070042447 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional)
02/22/2007US20070042432 Method of diagnosis and treatment
02/22/2007US20070041904 Peptides whose uptake by cells is controllable
02/22/2007US20070041903 Modified minigastrin analogs for oncology applications
02/22/2007US20070041902 Somatostatin analogs with inhibitory activity to growth hormone release
02/22/2007US20070041901 2'-O-methyl substituted nucleic acids specific to prostate specific membrane antigen (PSMA) for use in detection and targeting cancer tissues
02/22/2007US20070041900 Method and device for radiotherapy
02/22/2007US20070041899 Radiolabelled substrates
02/22/2007DE102004005280B4 Verfahren und pharmazeutischer Kit zur Herstellung von Rhenium-188 markierten Mikrosphären The method and pharmaceutical kit for the preparation of rhenium-188 labeled microspheres
02/22/2007CA2618988A1 Methods of making radiolabeled tracers and precursors thereof
02/21/2007EP1754788A2 Prostate-specific membrane antigen and uses thereof
02/21/2007EP1754712A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
02/21/2007EP1753468A2 Carboranylporphyrins and uses thereof
02/21/2007EP1753467A1 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents
02/21/2007EP1753466A2 Copolymers comprising positively and negatively charged aminoacids conjugated to chelants
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007EP0942996B8 Thrombolytic agents with antithrombotic activity
02/21/2007CN1917906A Improvement in the ligand protection for mercaptoacetyl triglycine
02/21/2007CN1301261C Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid and preparation method thereof
02/21/2007CN1301134C Novel immune effect compound
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007US7179449 Enhanced ultrasound detection with temperature-dependent contrast agents
02/20/2007US7179446 Administering to mammal vitronectin receptor targeted imaging agent and a perfusion imaging agent; concurrently detecting vitronectin receptor targeted imaging agent bound at vitronectin receptor and perfusion imaging agent; imaging
02/20/2007US7179445 Cobalamin conjugates useful as imaging and therapeutic agents
02/20/2007US7179444 Pendant fatty acid imaging agents
02/15/2007WO2007019376A2 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
02/15/2007WO2007019055A2 Cell delivery fluid for prevention of cellsettling in delivery system
02/15/2007WO2007018621A1 Drug delivery system and method
02/15/2007WO2006092584A3 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry
02/15/2007WO2006036071A3 Urokinase plasminogen activator receptor targeted contrast agent
02/15/2007US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer
02/15/2007US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors
02/15/2007US20070036720 Radiolabelled metal transport protein as imaging agent
02/15/2007US20070036719 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA)
02/15/2007US20070036718 Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives
02/15/2007US20070036717 Chemoradiotherapy with TS-1/camptothecins
02/15/2007US20070036716 Methods of making radiolabeled tracers and precursors thereof
02/15/2007US20070036715 Tc-labeled arylpiperazine derivatives for imaging serotonin receptor
02/15/2007US20070036714 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy
02/14/2007EP1750671A1 Liposomal assembly for therapeutic and/or diagnostic use
02/14/2007EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
02/14/2007EP1009726B1 Fluorination of proteins and peptides for f-18 positron emission tomography
02/14/2007CN1913926A Method and kit for the production of particles labelled with rhenium-188